TARRYTOWN, N.Y., Aug. 3 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) will Webcast its quarterly earnings conference call on Tuesday, August 7, 2007, at 10:00 AM EDT to discuss the results of its second quarter ended June 30, 2007. All interested parties are invited to listen to Emisphere's President/Chief Executive Officer Michael V. Novinski, and William Rumble, Corporate Controller, present the quarterly earnings results, highlights and future direction. Laura Kragie, MD, Vice President of Clinical Development and Chief Medical Officer, and Lewis H. Bender, Chief Technology Officer, will also be on the call. The live conference call dial-in number is: 1-800-819-9193 (US and Canada) or 1-913-981-4911 (International). To access a replay of the call, dial 1-888-203-1112 (US and Canada) or 1-719-457-0820 (International). The conference replay PIN is 9045496. Investors will also have the opportunity to listen to the conference call over the Internet through Emisphere's Web site at http://www.emisphere.com. To listen to the live call, please go to the Web site at least 10 minutes in advance for instructions. About Emisphere Technologies, Inc. Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its eligen(R) technology. These molecules and compounds could be currently available or are in pre-clinical or clinical development. Such molecules or compounds usually cannot be delivered by the oral route of administration or the benefits of these compounds are limited due to poor bioavailability, slow on-set of action or variable absorption. The eligen(R) technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, per rectum, pulmonary, intra-vaginal or transdermal. The Web site is: http://www.emisphere.com.
SOURCE Emisphere Technologies, Inc.